 Scleroderma in pregnancy is a complex situation; it increases the risk to both mother and child.Overall scleroderma is associated with reduced fetal weight for gestational age.The treatment for scleroderma often includes known teratogens such as cyclophosphamide, methotrexate, mycophenolate, etc.